Serum Institute of India Pvt. Ltd.
6
28M
6
0.21
2
2
- Areas of investment
Summary
Serum Institute of India Pvt. Ltd. is the famous Corporate Investor, which was founded in 1996. The company was established in Asia in India. The main office of represented Corporate Investor is situated in the Pune.
The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2019. The higher amount of exits for fund were in 2018. Deals in the range of 10 - 50 millions dollars are the general things for fund.
The usual cause for the fund is to invest in rounds with 8-9 partakers. Despite the Serum Institute of India Pvt. Ltd., startups are often financed by Polaris Partners, Flagship Pioneering, Vertex Ventures HC. The meaningful sponsors for the fund in investment in the same round are Alexandria Venture Investments, Vertex Ventures HC, Vertex Ventures.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in some founders of portfolio startups. Among the most popular fund investment industries, there are Clinical Trials, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight X-Vax Technology, Visterra. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
Investments analytics
Analytics
- Total investments
- 6
- Lead investments
- 2
- Exits
- 2
- Rounds per year
- 0.21
- Investments by industry
- Biotechnology (4)
- Therapeutics (2)
- Medical (2)
- Genetics (2)
- Clinical Trials (1) Show 7 more
- Investments by region
-
- United States (4)
- United Kingdom (1)
- India (1)
- Peak activity year
- 2021
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 16
- Avg. valuation at time of investment
- 83M
- Group Appearance index
- 0.50
- Avg. company exit year
- 18
- Avg. multiplicator
- 1.75
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Codagenix | 15 Feb 2023 | Biotechnology, Genetics | Early Stage Venture | 25M | United States, New York |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.